2025
SJR Q2
JCR Q3 · 1,6
2 matched articles
SCIE
SSCI
Journal detail
Experimental and Clinical Psychopharmacology
- Publisher
- American Psychological Association
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1064129719362293
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,796
- Quartile Q2
- H-Index 105
- Cites/doc 1,76
- Docs (3y) 235
- Cites (3y) 555
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,6
- 5Y JIF 2,5
- JCI 0,65
WoS indexes
- SCIE
- SSCI
Subject classification
Categories (SJR)
- Pharmacology Q2
- Pharmacology (medical) Q2
- Psychiatry and Mental Health Q2
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy | Psychiatry
- Psychology, Biological | Psychology, Clinical
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,796 | 1,6 | 2,5 | 0,65 | Q2 | 105 |
| 2024 | Q1 | Q2 | 1,004 | 2,2 | 2,5 | 0,76 | Q2 | 104 |
| 2023 | Q2 | Q2 | 0,827 | 2,4 | 2,4 | 0,78 | Q2 | 104 |
| 2022 | Q2 | Q3 | 0,718 | 2,3 | 2,6 | 0,82 | Q2 | 104 |
| 2021 | Q2 | Q2 | 0,856 | 3,5 | 3,2 | 0,86 | Q2 | 104 |
| 2020 | Q1 | Q2 | 1,066 | 3,2 | 3,4 | 0,89 | Q2 | 104 |
| 2019 | Q2 | Q2 | 0,922 | 2,2 | 2,6 | 0,78 | Q2 | 104 |
| 2018 | — | Q3 | — | 1,9 | 2,6 | 0,83 | Q2 | — |
| 2017 | Q1 | Q2 | 1,176 | 2,4 | 2,7 | 0,86 | Q2 | 104 |
| 2016 | Q1 | Q2 | 1,275 | 2,2 | 2,6 | — | — | 104 |
| 2015 | Q1 | Q2 | 1,373 | 2,1 | 2,7 | — | — | 104 |
| 2014 | Q1 | Q1 | 1,477 | 2,7 | 3,3 | — | — | 104 |
| 2013 | Q1 | Q1 | 1,362 | 2,6 | 3 | — | — | 104 |
| 2012 | Q1 | Q1 | 1,472 | 2,5 | 3,2 | — | — | 104 |
| 2011 | Q1 | Q1 | 1,214 | 2,6 | 2,8 | — | — | 104 |
| 2010 | Q1 | Q1 | 1,313 | 2,7 | 2,7 | — | — | 104 |
| 2009 | — | Q1 | — | 2,7 | 2,7 | — | — | — |
| 2008 | — | Q2 | — | 2,3 | 2,6 | — | — | — |
| 2007 | — | Q1 | — | 2 | 2,6 | — | — | — |
| 2006 | — | Q2 | — | 1,6 | — | — | — | — |
| 2005 | — | Q1 | — | 2 | — | — | — | — |
| 2004 | — | Q1 | — | 1,7 | — | — | — | — |
| 2003 | — | Q1 | — | 1,6 | — | — | — | — |
| 2002 | — | Q1 | — | 1,7 | — | — | — | — |
| 2001 | — | Q1 | — | 1,7 | — | — | — | — |
| 2000 | — | Q1 | — | 1,7 | — | — | — | — |
| 1999 | — | Q2 | — | 1,2 | — | — | — | — |
| 1998 | — | Q1 | — | 1,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q2 | 276/356 |
| 2025 | PSYCHIATRY | SCIE | Q3 | Q3 | 213/293 |
| 2025 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q3 | Q3 | 11/17 |
| 2025 | PSYCHOLOGY, CLINICAL | SSCI | Q3 | Q3 | 115/184 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 209/352 |
| 2024 | PSYCHIATRY | SCIE | Q3 | Q2 | 152/288 |
| 2024 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | Q2 | 8/18 |
| 2024 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | Q2 | 78/185 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 188/354 |
| 2023 | PSYCHIATRY | SCIE | Q2 | Q2 | 126/279 |
| 2023 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | Q2 | 7/18 |
| 2023 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | Q2 | 65/180 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 200/278 |
| 2022 | PSYCHIATRY | SCIE | Q3 | Q2 | 115/155 |
| 2022 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q3 | Q2 | 8/14 |
| 2022 | PSYCHOLOGY, CLINICAL | SSCI | Q3 | Q2 | 79/131 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 147/279 |
| 2021 | PSYCHIATRY | SCIE | Q3 | Q2 | 90/155 |
| 2021 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | Q2 | 5/14 |
| 2021 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | Q2 | 58/131 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 153/276 |
| 2020 | PSYCHIATRY | SCIE | Q3 | Q2 | 87/156 |
| 2020 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | Q2 | 6/14 |
| 2020 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | Q2 | 58/130 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 179/271 |
| 2019 | PSYCHIATRY | SCIE | Q3 | Q2 | 90/155 |
| 2019 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | Q2 | 7/14 |
| 2019 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | Q2 | 53/131 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 186/267 |
| 2018 | PSYCHIATRY | SCIE | Q3 | Q2 | 94/146 |
| 2018 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q3 | Q2 | 10/14 |
| 2018 | PSYCHOLOGY, CLINICAL | SSCI | Q3 | Q2 | 66/130 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 139/261 |
| 2017 | PSYCHIATRY | SCIE | Q3 | Q2 | 72/142 |
| 2017 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | Q2 | 7/14 |
| 2017 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | Q2 | 48/127 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 151/257 |
| 2016 | PSYCHIATRY | SCIE | Q3 | — | 78/142 |
| 2016 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/14 |
| 2016 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | — | 47/121 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 143/255 |
| 2015 | PSYCHIATRY | SCIE | Q3 | — | 74/142 |
| 2015 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q3 | — | 8/14 |
| 2015 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | — | 43/122 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 102/255 |
| 2014 | PSYCHIATRY | SCIE | Q2 | — | 56/140 |
| 2014 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/14 |
| 2014 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 27/119 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 101/256 |
| 2013 | PSYCHIATRY | SCIE | Q2 | — | 57/136 |
| 2013 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/14 |
| 2013 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 27/111 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 108/261 |
| 2012 | PSYCHIATRY | SCIE | Q2 | — | 57/135 |
| 2012 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 6/14 |
| 2012 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 24/114 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 103/261 |
| 2011 | PSYCHIATRY | SCIE | Q2 | — | 53/130 |
| 2011 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 6/14 |
| 2011 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 25/110 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 92/252 |
| 2010 | PSYCHIATRY | SCIE | Q2 | — | 47/128 |
| 2010 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 6/14 |
| 2010 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 18/104 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/237 |
| 2009 | PSYCHIATRY | SCIE | Q2 | — | 48/117 |
| 2009 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/14 |
| 2009 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 21/93 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 112/219 |
| 2008 | PSYCHIATRY | SCIE | Q3 | — | 55/101 |
| 2008 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 6/14 |
| 2008 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | — | 23/88 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/205 |
| 2007 | PSYCHIATRY | SCIE | Q3 | — | 55/94 |
| 2007 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q3 | — | 11/15 |
| 2007 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 21/87 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 119/199 |
| 2006 | PSYCHIATRY | SCIE | Q3 | — | 62/94 |
| 2006 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q4 | — | 12/15 |
| 2006 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | — | 29/86 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 92/193 |
| 2005 | PSYCHIATRY | SCIE | Q3 | — | 52/94 |
| 2005 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/15 |
| 2005 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 15/83 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 101/187 |
| 2004 | PSYCHIATRY | SCIE | Q3 | — | 50/90 |
| 2004 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/16 |
| 2004 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 19/84 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 98/185 |
| 2003 | PSYCHIATRY | SCIE | Q3 | — | 51/87 |
| 2003 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 8/16 |
| 2003 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 19/83 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/188 |
| 2002 | PSYCHIATRY | SCIE | Q3 | — | 50/88 |
| 2002 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/15 |
| 2002 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 18/83 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 69/186 |
| 2001 | PSYCHIATRY | SCIE | Q3 | — | 41/81 |
| 2001 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 7/15 |
| 2001 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 12/79 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/181 |
| 2000 | PSYCHIATRY | SCIE | Q2 | — | 37/82 |
| 2000 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q1 | — | 3/15 |
| 2000 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 11/82 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 84/175 |
| 1999 | PSYCHIATRY | SCIE | Q3 | — | 42/80 |
| 1999 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q3 | — | 10/15 |
| 1999 | PSYCHOLOGY, CLINICAL | SSCI | Q2 | — | 22/87 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 65/178 |
| 1998 | PSYCHIATRY | SCIE | Q2 | — | 29/77 |
| 1998 | PSYCHOLOGY, BIOLOGICAL | SSCI | Q2 | — | 5/16 |
| 1998 | PSYCHOLOGY, CLINICAL | SSCI | Q1 | — | 13/87 |